Related Experiment Videos
Case study: periodic follow-up is necessary in morphea profunda to identify systemic evolution
Lucilla Melani1, Carla Cardinali, Barbara Giomi
1Department of Dermatological Sciences, University of Florence, Italy.
Skinmed
|May 14, 2005
Summary
This case study details morphea profunda, a rare scleroderma variant, in a young man with widespread skin lesions and potential systemic involvement. Early diagnosis and treatment are crucial for managing this disabling condition.
Area of Science:
- Dermatology
- Rheumatology
- Pathology
Background:
- Morphea encompasses diverse localized scleroderma forms, ranging from cosmetic concerns to severe morbidity.
- Deep morphea and pediatric pansclerotic morphea can lead to significant patient disability.
Observation:
- A 40-year-old man presented with rapidly progressive, widespread subcutaneous indurations and scleroatrophic plaques.
- Clinical examination revealed characteristic sclerotic plaques with a "lilac ring" and band-like distribution.
- Histopathology confirmed morphea profunda with dermal and fascial fibrosis, and muscle involvement.
Findings:
- Elevated circulating immunocomplexes binding C1q were noted.
- Nailfold capillaroscopy showed nonspecific connective tissue disease findings.
- Initial treatment with amino benzoic potassium, prednisone, and topical clobetasol yielded moderate improvement.
Implications:
- This case highlights the potential for systemic evolution in morphea profunda.
- Emphasizes the importance of thorough clinical and histopathological evaluation for accurate diagnosis.
- Suggests the need for further research into effective therapeutic strategies for deep morphea.